These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6975766

  • 1. Synthetic C3a analogs as specific inhibitors of C3a activity.
    Meuer S, Hadding U, Andreatta R, Bitter-Suermann D.
    Immunopharmacology; 1981 Sep; 3(3):275-80. PubMed ID: 6975766
    [Abstract] [Full Text] [Related]

  • 2. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S, Hugli TE, Andreatta RH, Hadding U, Bitter-Suermann D.
    Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
    [Abstract] [Full Text] [Related]

  • 3. The active site of human C4a anaphylatoxin.
    Hugli TE, Kawahara MS, Unson CG, Molinar-Rode R, Erickson BW.
    Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
    [Abstract] [Full Text] [Related]

  • 4. C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.
    Zanker B, Rasokat H, Hadding U, Bitter-Suermann D.
    Agents Actions Suppl; 1982 Jun; 11():147-57. PubMed ID: 6983827
    [Abstract] [Full Text] [Related]

  • 5. Induction of platelet aggregation by the complement-derived peptides C3a and C5a.
    Grossklaus C, Damerau B, Lemgo E, Vogt W.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):71-6. PubMed ID: 1004644
    [Abstract] [Full Text] [Related]

  • 6. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
    Sorgenfrei J, Damerau B, Vogt W.
    Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of human anaphylatoxins on guinea pig atria.
    Huey R, Bloor CM, Hugli TE.
    Immunopharmacology; 1984 Dec; 8(3-4):147-54. PubMed ID: 6335143
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    Marceau F, Hugli TE.
    J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Platelet activation: a new biological activity of guinea-pig C3a anaphylatoxin.
    Becker S, Meuer S, Hadding U, Bitter-Suermann D.
    Scand J Immunol; 1978 Sep; 7(2):173-80. PubMed ID: 653315
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cardiac dysfunction caused by purified human C3a anaphylatoxin.
    del Balzo UH, Levi R, Polley MJ.
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):886-90. PubMed ID: 2579381
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anaphylatoxin-induced neutrophil chemotaxis and aggregation. Limited aggregation and specific desensitization induced by human C3a and synthetic C3a octapeptides.
    Nagata S, Glovsky MM, Kunkel SL.
    Int Arch Allergy Appl Immunol; 1987 Feb; 82(1):4-9. PubMed ID: 3492446
    [Abstract] [Full Text] [Related]

  • 19. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W, Kretzschmar T, Stühmer T, Kola A, Emde M, Köhl J, Klos A, Bitter-Suermann D.
    Biochem J; 1992 Nov 15; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [Abstract] [Full Text] [Related]

  • 20. Anaphylatoxin-induced release of histamine from in vitro perfused guinea pig kidney.
    Abdullah NA, Assem ES, Damerau B.
    Agents Actions; 1988 Apr 15; 23(3-4):181-4. PubMed ID: 2455983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.